港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

來凱醫藥-B

11.460

+0.1601.42%

成交量：124.70萬

成交額：1,443.54萬

市值：46.76億

市盈率：-15.16

高：11.960

開：11.540

低：11.220

收：11.300

資料載入中...

總覽公司新聞公告

港股異動 | 來凱醫藥-B(02105)漲超8% 自研新藥LAE120獲美國FDA臨牀試驗批准

來凱醫藥-B盤中異動快速上漲5.43%

天風證券：中國創新藥產業趨勢已較為明確並迅速加強有望共享全球藥品銷售市場

來凱醫藥-B02月28日遭主力拋售105萬元

來凱醫藥-B盤中異動早盤快速下挫5.12%

來凱醫藥-B盤中異動股價大漲5.18%

港股異動丨來凱醫藥拉昇漲超12%，創年內新高

來凱醫藥-B盤中異動早盤大幅上漲5.01%報13.000港元

來凱醫藥－Ｂ(02105)股價上升5.19%，現價港幣$12.16

阿斯达克财经

禮來首次披露新型減重藥個案數據來凱醫藥(02105)已成中國ActRII靶點“領軍者”

來凱醫藥-B盤中異動快速下挫6.48%報11.840港元

格隆匯個股放量排行榜 | 2月23日

來凱醫藥－Ｂ(02105)股價顯著波動11.577%，現價港幣$11.32

阿斯达克财经

來凱醫藥－Ｂ(02105)股價下跌5.034%，現價港幣$11.32

阿斯达克财经

來凱醫藥-B盤中異動早盤大幅上漲5.54%

更正-資料盒-脂肪而非肌肉：製藥商競相尋求下一個減肥突破

來凱醫藥-B02月19日主力資金流入159萬元連續3日加倉

來凱醫藥-B盤中異動早盤股價大漲5.32%報11.880港元

中國內地投資者週二港股通淨買入額創四年來最高

來凱醫藥－Ｂ(02105)股價大幅上升21.105%，現價港幣$10.96

阿斯达克财经

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02105/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02105","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02105\",,,,,undefined,":{"symbol":"02105","market":"HK","secType":"STK","nameCN":"來凱醫藥-B","latestPrice":11.46,"timestamp":1744877289031,"preClose":11.3,"halted":0,"volume":1247000,"delay":0,"floatShares":408000000,"shares":408000000,"eps":-0.7560241273067456,"marketStatus":"休市中","change":0.16,"latestTime":"04-17 16:08:09","open":11.54,"high":11.96,"low":11.22,"amount":14435375,"amplitude":0.065487,"askPrice":11.52,"askSize":500,"bidPrice":11.46,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":-0.7560241273067456,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1745285400000},"marketStatusCode":7,"adr":0,"listingDate":1687968000000,"exchange":"SEHK","adjPreClose":11.3,"openAndCloseTimeList":[[1744853400000,1744862400000],[1744866000000,1744876800000]],"volumeRatio":0.5022757481996416,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02105\",,,,,undefined,":{"symbol":"02105","floatShares":408000000,"roa":"-19.08%","roe":"-31.61%","lyrEps":-0.756024,"volumeRatio":0.5022757481996416,"shares":408000000,"dividePrice":0,"high":11.96,"amplitude":0.065487,"preClose":11.3,"low":11.22,"week52Low":3.9,"pbRate":"5.46","psRate":"8392.43","week52High":17.78,"institutionHeld":0,"latestPrice":11.46,"committee":0.333333,"eps":-0.7560241273067456,"divideRate":0,"volume":1247000,"delay":0,"ttmEps":-0.7560241273067456,"open":11.54,"prevYearClose":9.37,"prevWeekClose":10.64,"prevMonthClose":14.48,"prevQuarterClose":14.48,"fiveDayClose":9.32,"twentyDayClose":13.8,"sixtyDayClose":9.95},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02105\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516575333","title":"港股異動 | 來凱醫藥-B(02105)漲超8% 自研新藥LAE120獲美國FDA臨牀試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2516575333","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516575333?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 11:29","pubTimestamp":1740972568,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，来凯医药-B涨超8%，截至发稿，涨8.63%，报13.6港元，成交额8370.23万港元。消息面上，来凯医药今早宣布，美国食品药品监督管理局已批准其自主研发的LAE120，一种强效、高选择性USP1抑制剂的新药临床试验申请，用于治疗晚期实体瘤患者。公司表示正积极开展外部合作以加快LAE120临床开发进展。除LAE120，来凯自主研发的另一款抗肿瘤潜在药物LAE118也进入了IND支持性研究阶段。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1256765.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02105","BK1141","03347","BK1576","BK1583","BK1161"],"gpt_icon":0},{"id":"2516242175","title":"來凱醫藥-B盤中異動 快速上漲5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516242175","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516242175?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 09:31","pubTimestamp":1740965483,"startTime":"0","endTime":"0","summary":"2025年03月03日早盘09时31分，来凯医药-B股票出现波动，股价快速上涨5.43%。截至发稿，该股报13.200港元/股，成交量31.65万股，换手率0.08%，振幅2.88%。来凯医药-B股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，北海康成-B、永泰生物-B、来凯医药-B涨幅较大，振幅较大的相关个股有永泰生物-B、科伦博泰生物-B、腾盛博药-B，振幅分别为6.79%、5.45%、4.69%。LAE001是雄性激素合成抑制剂,可同时抑制CYP17A1及CYP11B2。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030309312398992674&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030309312398992674&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2516513487","title":"天風證券：中國創新藥產業趨勢已較為明確並迅速加強 有望共享全球藥品銷售市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2516513487","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516513487?lang=zh_tw&edition=fundamental","pubTime":"2025-03-02 17:25","pubTimestamp":1740907559,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，天风证券发布研究报告称，站在当前时点，中国创新药行业的产业趋势已较为明确并迅速加强。一个是创新品种在中国获批上市，带来收入以及利润;一个是创新能力加强，BIC 潜力管线海外权益授出带来收入以及利润。从节奏来看，天风证券认为两个逻辑都处在加强阶段。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1256601.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2328871848.SGD","02105","LU2488822045.USD","01801","02256","601162","BK0276","BK1583","01952","BK1191","BK1589","06978","LU1969619763.USD","BK1161","BK1574","03692","159992"],"gpt_icon":0},{"id":"2514488983","title":"來凱醫藥-B02月28日遭主力拋售105萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514488983","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514488983?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 16:16","pubTimestamp":1740730604,"startTime":"0","endTime":"0","summary":"02月28日, 来凯医药-B股价跌2.80%，报收12.52元，成交金额1.16亿元，换手率2.20%，振幅12.73%，量比0.95。来凯医药-B今日主力资金净流出105万元，上一交易日主力净流出48万元。该股近5个交易日下跌1.11%，主力资金累计净流入1192万元；近20日主力资金累计净流入3290万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228165610a2579d18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228165610a2579d18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2514087369","title":"來凱醫藥-B盤中異動 早盤快速下挫5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514087369","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514087369?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 09:56","pubTimestamp":1740707814,"startTime":"0","endTime":"0","summary":"2025年02月28日早盘09时56分，来凯医药-B股票出现波动，股价急速下跌5.12%。截至发稿，该股报12.220港元/股，成交量88.6万股，换手率0.22%，振幅6.83%。来凯医药-B股票所在的生物技术行业中，整体涨幅为1.35%。其相关个股中，百济神州、正大企业国际、方达控股涨幅较大，振幅较大的相关个股有科笛-B、宜明昂科-B、腾盛博药-B，振幅分别为14.48%、12.67%、12.44%。LAE001是雄性激素合成抑制剂,可同时抑制CYP17A1及CYP11B2。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228095654a2571cb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228095654a2571cb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2514811422","title":"來凱醫藥-B盤中異動 股價大漲5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514811422","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514811422?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 09:54","pubTimestamp":1740621260,"startTime":"0","endTime":"0","summary":"2025年02月27日早盘09时54分，来凯医药-B股票出现异动，股价快速上涨5.18%。截至发稿，该股报13.820港元/股，成交量154.25万股，换手率0.38%，振幅5.63%。资金方面，该股资金流入1106.28万港元，流出675.528万港元。来凯医药-B股票所在的生物技术行业中，整体涨幅为0.41%。其相关个股中，北海康成-B、康宁杰瑞制药-B、科济药业-B涨幅较大，振幅较大的相关个股有北海康成-B、科济药业-B、康宁杰瑞制药-B，振幅分别为58.68%、18.33%、17.10%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227095420989437fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227095420989437fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2514810078","title":"港股異動丨來凱醫藥拉昇漲超12%，創年內新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2514810078","media":"格隆汇","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514810078?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 10:09","pubTimestamp":1740535779,"startTime":"0","endTime":"0","summary":"来凯医药-B盘初拉升涨超12%，报13.88港元，股价创去年12月12日以来新高。LAE102是来凯医药自主研发针对Act RIIA的单克隆抗体，Act RIIA是在肌肉再生和脂肪代谢中发挥重要作用的受体。LAE102与GLP-1受体激动剂联用可进一步减少脂肪并显著降低GLP-1受体激动剂导致的肌肉流失，使LAE102成为一种高质量体重控制候选药物。还值得注意的是，2024年11月20日，来凯医药发布公告称，公司已与礼来公司签订一项临床合作协议，旨在支持和加速LAE102针对肥胖症治疗的全球临床开发。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/26100948391307.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2514029022","title":"來凱醫藥-B盤中異動 早盤大幅上漲5.01%報13.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514029022","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514029022?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 09:38","pubTimestamp":1740533880,"startTime":"0","endTime":"0","summary":"2025年02月26日早盘09时38分，来凯医药-B股票出现异动，股价快速上涨5.01%。截至发稿，该股报13.000港元/股，成交量58.6万股，换手率0.14%，振幅7.92%。资金方面，该股资金流入422.761万港元，流出200.408万港元。来凯医药-B股票所在的生物技术行业中，整体涨幅为0.16%。其相关个股中，创胜集团-B、科济药业-B、三叶草生物-B涨幅较大，振幅较大的相关个股有创胜集团-B、科济药业-B、来凯医药-B，振幅分别为14.71%、11.27%、7.92%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226093800abdd15fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226093800abdd15fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2514659038","title":"來凱醫藥－Ｂ(02105)股價上升5.19%，現價港幣$12.16","url":"https://stock-news.laohu8.com/highlight/detail?id=2514659038","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514659038?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 10:55","pubTimestamp":1740452100,"startTime":"0","endTime":"0","summary":"[上升股]来凯医药－Ｂ(02105) 股价在上午10:55比前收市价上升5.19%，现股价为港币$12.16。至目前为止，今日最高价为$12.16，而最低价为$10.88。总成交量为314.85万股，总成交金额为港币$3.549千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2502251328/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2514085237","title":"禮來首次披露新型減重藥個案數據 來凱醫藥(02105)已成中國ActRII靶點“領軍者”","url":"https://stock-news.laohu8.com/highlight/detail?id=2514085237","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514085237?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 08:38","pubTimestamp":1740443915,"startTime":"0","endTime":"0","summary":"2024年6月，来凯医药的LAE102针对超重/肥胖适应症，在中国开展的I期临床试验就已经启动，并完成了首例受试者给药。来凯医药在ActRIIA靶点的快速进展，甚至引起了手握Bimagrumab的全球巨头礼来的关注。根据双方的协议，礼来将负责在美国执行一项I期临床研究并承担相关费用，而来凯医药则保留LAE102的全球权利。同时，来凯医药在ActRII靶点已经完成了全面的布局：靶向ActRIIA的抗体LAE102以及靶向ActRIIB的抗体LAE103，以及对标Bimagrumab、同时靶向ActRIIA/IIB的双靶点抗体LAE123。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1253777.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2264538146.SGD","LU1035775433.USD","LU1023059063.AUD","LU1267930730.SGD","LU2237443622.USD","LU0354030438.USD","LU1057294990.SGD","LU1623119135.USD","LU2491049909.HKD","LU1064131342.USD","SG9999015952.SGD","LU2237443978.SGD","LU0256863902.USD","02105","LU1868837300.USD","LU2361044949.HKD","BK4581","BK4599","LLY","LU1291159041.SGD","IE0009355771.USD","LU0354030511.USD","LU2237443465.HKD","LU2106854487.HKD","SG9999014898.SGD","LU0417517546.SGD","LU0672654240.SGD","LU2237443549.SGD","LU0097036916.USD","SG9999014880.SGD","LU1280957306.USD","LU2602419157.SGD","SG9999013999.USD","LU0640476718.USD","LU1988902786.USD","SGXZ31699556.SGD","BK4588","LU1720051108.HKD","LU0079474960.USD","LU0820561818.USD","LU2361044865.SGD","LU0061475181.USD","IE00BJLML261.HKD","LU1868836914.USD","LU0943347566.SGD","SG9999015978.USD","LU2324357040.USD","SG9999001176.USD","SG9999014914.USD","LU1989771016.USD"],"gpt_icon":1},{"id":"2513608087","title":"來凱醫藥-B盤中異動 快速下挫6.48%報11.840港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513608087","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513608087?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 09:30","pubTimestamp":1740360647,"startTime":"0","endTime":"0","summary":"2025年02月24日早盘09时30分，来凯医药-B股票出现波动，股价快速跳水6.48%。截至发稿，该股报11.840港元/股，成交量8.2万股，换手率0.02%，振幅6.16%。资金方面，该股资金流入2.957万港元，流出68.867万港元。来凯医药-B股票所在的生物技术行业中，整体跌幅为1.51%。其相关个股中，创胜集团-B、歌礼制药-B、再鼎医药涨幅较大，振幅较大的相关个股有来凯医药-B、晶泰控股-P、药明合联，振幅分别为6.16%、6.02%、5.31%。LAE001是雄性激素合成抑制剂,可同时抑制CYP17A1及CYP11B2。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224093047962dcdba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224093047962dcdba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2513739837","title":"格隆匯個股放量排行榜 | 2月23日","url":"https://stock-news.laohu8.com/highlight/detail?id=2513739837","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513739837?lang=zh_tw&edition=fundamental","pubTime":"2025-02-23 17:30","pubTimestamp":1740303003,"startTime":"0","endTime":"0","summary":"格隆汇勾股大数据显示，上一交易日中创新航(03931)、开拓药业-B(09939)、首程控股(00697)、飞天云动(06610)、中国环境资源(01130)、先声药业(02096)、三叶草生物-B(02197)、药明康德(02359)、华润医疗(01515)、康龙化成(03759)、京信通信(02342)、山高控股(00412)、亚信科技(01675)、恒基地产(00012)、中国联通(0076","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/23173048332183.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02567","01093","01675","09885","02339","01349","01815","03833","00762","02560","00144","00839","03698","09959","00013","01616","00412","02105","02556","02410","02096","02678","06680","00363","00565","02878","00400","00340","02126","01696","08071","01769","01665","01268","06616","00288","02440","00302","02246","06881","00547","00697","03382","06908","02268","00696","02100","00867"],"gpt_icon":1},{"id":"2512546006","title":"來凱醫藥－Ｂ(02105)股價顯著波動11.577%，現價港幣$11.32","url":"https://stock-news.laohu8.com/highlight/detail?id=2512546006","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512546006?lang=zh_tw&edition=fundamental","pubTime":"2025-02-20 13:05","pubTimestamp":1740027900,"startTime":"0","endTime":"0","summary":"[异动股]来凯医药－Ｂ(02105) 股价在下午01:05出现显著波动11.577%，现股价为港币$11.32，比前收市价下跌5.034%5.034%。至目前为止，今日最高价为$12.7，而最低价为$11.32。总成交量为691.75万股，总成交金额为港币$8.341千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725131625308_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725131625308_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAC25022080/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2512062460","title":"來凱醫藥－Ｂ(02105)股價下跌5.034%，現價港幣$11.32","url":"https://stock-news.laohu8.com/highlight/detail?id=2512062460","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512062460?lang=zh_tw&edition=fundamental","pubTime":"2025-02-20 13:05","pubTimestamp":1740027900,"startTime":"0","endTime":"0","summary":"[下跌股]来凯医药－Ｂ(02105) 股价在下午01:05比前收市价下跌5.034%，现股价为港币$11.32。至目前为止，今日最高价为$12.7，而最低价为$11.32。总成交量为691.55万股，总成交金额为港币$8.339千万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2502203081/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2512246373","title":"來凱醫藥-B盤中異動 早盤大幅上漲5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512246373","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512246373?lang=zh_tw&edition=fundamental","pubTime":"2025-02-20 10:05","pubTimestamp":1740017137,"startTime":"0","endTime":"0","summary":"2025年02月20日早盘10时05分，来凯医药-B股票出现异动，股价大幅拉升5.54%。截至发稿，该股报12.580港元/股，成交量217.25万股，换手率0.53%，振幅6.54%。资金方面，该股资金流入1310.58万港元，流出735.475万港元。来凯医药-B股票所在的生物技术行业中，整体涨幅为1.07%。其相关个股中，歌礼制药-B、腾盛博药-B、昭衍新药涨幅较大，振幅较大的相关个股有腾盛博药-B、歌礼制药-B、昭衍新药，振幅分别为23.39%、21.29%、17.46%。LAE001是雄性激素合成抑制剂,可同时抑制CYP17A1及CYP11B2。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220100537abd587fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220100537abd587fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2512170557","title":"更正-資料盒-脂肪而非肌肉：製藥商競相尋求下一個減肥突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2512170557","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512170557?lang=zh_tw&edition=fundamental","pubTime":"2025-02-19 19:00","pubTimestamp":1739962807,"startTime":"0","endTime":"0","summary":"更正-资料盒-脂肪而非肌肉：制药商竞相寻求下一个减肥突破将第16段中的 \"Elevai Biosciences \"更正为 \"Northstrive Biosciences\"。路透社2月19日 - 目前的减肥方法，如改变生活方式、手术以及诺和诺德公司NOVOb.CO的Wegovy和礼来公司LLY.N的Zepbound等流行疗法，都会导致脂肪和肌肉流失，从而增加跌倒的风险并降低整体力量，这对老年患者尤其有害。以下公司正在开发减肥疗法 ，帮助患者在减重的同时保持或增加肌肉：","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250219:nL3T3PA0QG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1035775433.USD","VERU","LU1366192091.USD","LU0310800965.SGD","LU2023251221.USD","ELAB","LU1720051108.HKD","LU0198837287.USD","LU1153584641.USD","LU2237443978.SGD","ALT","LU1880407215.USD","LU0122379950.USD","BK4584","LU0171293334.USD","LU2089283258.USD","LU1989772923.USD","LU0545039389.USD","LU0047473722.SGD","LU0957799991.USD","REGN","LU1548497426.USD","BK4585","LU1989771016.USD","SGXZ31699556.SGD","LLY","LU0820561909.HKD","LU1051770623.HKD","03165","ARWR","02105","AZN.UK","BHVN","IE00BJLML261.HKD","KROS","LU0784384876.USD","LU0106261372.USD","LU2063271972.USD","LU2324357040.USD","SRRK","LU0096364046.USD","LU0211327993.USD","LU0792757196.USD","LU2602419157.SGD","SGXZ57979304.SGD","LU0354030438.USD","LU0310800379.SGD","SG9999017495.SGD","LU1093756168.USD","LU0964806797.USD"],"gpt_icon":0},{"id":"2512117816","title":"來凱醫藥-B02月19日主力資金流入159萬元 連續3日加倉","url":"https://stock-news.laohu8.com/highlight/detail?id=2512117816","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512117816?lang=zh_tw&edition=fundamental","pubTime":"2025-02-19 16:16","pubTimestamp":1739952967,"startTime":"0","endTime":"0","summary":"02月19日, 来凯医药-B股价涨5.67%，报收11.92元，成交金额1.20亿元，换手率2.52%，振幅12.41%，量比0.91。来凯医药-B今日主力资金净流入159万元，连续3日净流入，上一交易日主力净流入570万元。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为50.00%，平均涨幅为9.15%。该股近5个交易日上涨23.91%，主力资金累计净流入1055万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入1740万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219161636a24b98ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219161636a24b98ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2512143218","title":"來凱醫藥-B盤中異動 早盤股價大漲5.32%報11.880港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512143218","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512143218?lang=zh_tw&edition=fundamental","pubTime":"2025-02-19 09:31","pubTimestamp":1739928712,"startTime":"0","endTime":"0","summary":"2025年02月19日早盘09时31分，来凯医药-B股票出现异动，股价大幅上涨5.32%。截至发稿，该股报11.880港元/股，成交量39.6万股，换手率0.10%，振幅5.50%。资金方面，该股资金流入201.595万港元，流出113.523万港元。来凯医药-B股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，来凯医药-B、科济药业-B、金斯瑞生物科技涨幅较大，振幅较大的相关个股有三叶草生物-B、来凯医药-B、晶泰控股-P，振幅分别为6.90%、5.50%、4.17%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219093152988a7573&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219093152988a7573&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2512111961","title":"中國內地投資者週二港股通淨買入額創四年來最高","url":"https://stock-news.laohu8.com/highlight/detail?id=2512111961","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512111961?lang=zh_tw&edition=fundamental","pubTime":"2025-02-19 07:37","pubTimestamp":1739921873,"startTime":"0","endTime":"0","summary":"中国内地投资者周二通过港股通净买入224亿港元的香港股票，继续推动DeepSeek引发的科技股涨势。彭博数据显示，这是自2021年初以来最大单日净买入，也是有纪录以来第四高。恒生科技指数当日大涨2.5%，有望连续第六周上涨。内地资金大量涌入香港股市，已推动A股市场相较港股的溢价幅度缩小至约34%，这使得一项A-H股溢价指数接近在过去总会触发反弹的底部，引发了香港上市中资股跑赢内地股票的幅度可能缩小的担忧。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190739199627f2f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190739199627f2f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06808","00762","00392","02382","00288","01929","02386","06616","02291","00826","06618","00189","01530","01675","01952","01341","02099","09696","00939","01128","01787","02105","03918","02172","09688","00013","00836","03969","01818","03800","00293","01357","02883","09987","01066","09988","03396","02607","02155","01686","00270","02400","02338","06690","02162","09868","00006","01772","02208","06680","01519","00152","01405","01735","02269","02465","00856","02618","00659","00666","00467","01618","00008","00981","00751","01119","03968","02186","00003","09969","00425","01070","01876","00855","02057","09880","00144","00175","01211","00590","09926","00548","00303","01513","00148","02096","02533","01093","00991","01177","02402","01691","01921","01907","01855","02018","06060","02005","03311","01810","00177","00576","00371","02380","06821","02015","00220","00014","02333","00777","02121","03618","02688","00327","06198","09858","00512","03606","BK1536","01199","01558","06699","02367","02171","03360","00853","01347","03692","09992","BK1133","09995","06855","00772","HSCEI","06069","02268","02498","09890","00241","06160","BK1506","01789","02601","01071","00107","00384","02016","SG9999002463.SGD","03933","00300","03650","01585","02158","00316","00868","01193","01860","00038","09626","01112","06127","09923","00788","00861","00005","00867","03690","00257","03369","02282","03988","06818","01138","01310","02359","01963","BK1589","02600","01658","02157","00267","00728","01919","06110","01766","00317","HSTECH","09922","09885","00546","01052","03328","00142","00412","06181","06990","01579","03888","06186","01024","01888","06936","00819","09899","01541"],"gpt_icon":0},{"id":"2512153419","title":"來凱醫藥－Ｂ(02105)股價大幅上升21.105%，現價港幣$10.96","url":"https://stock-news.laohu8.com/highlight/detail?id=2512153419","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512153419?lang=zh_tw&edition=fundamental","pubTime":"2025-02-17 15:10","pubTimestamp":1739776200,"startTime":"0","endTime":"0","summary":"[上升股]来凯医药－Ｂ(02105) 股价在下午03:10比前收市价大幅上升21.105%，现股价为港币$10.96。至目前为止，今日最高价为$10.96，而最低价为$8.74。总成交量为1.882千万股，总成交金额为港币$1.849亿。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2502173772/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02105","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02105\",params:#limit:5,,,undefined,":[{"date":"2025-03-24","symbol":"02105","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"盤後","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-16","symbol":"02105","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723771800000,"name":null,"time":"盤後","dateTimestamp":1723737600000,"actualEps":null},{"date":"2024-03-26","symbol":"02105","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711416600000,"name":null,"time":"","dateTimestamp":1711382400000,"actualEps":null},{"date":"2023-08-24","symbol":"02105","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692840600000,"name":null,"time":"","dateTimestamp":1692806400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02105\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02105\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02105\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02105","date":"2025-04-17","current":-15.831036,"percent":0.067265,"low":-20.235293,"twenty":-11.83884,"median":-7.042573,"eighty":-4.481028,"high":-1.640852,"avg":-8.190906,"sd":4.277952,"marketCap":4281657466},"quantilePoints":[{"date":"2023-06-30","current":-7.785551,"twenty":-6.73679,"median":-5.163648,"eighty":-3.590506,"marketCap":6577091901},{"date":"2023-07-07","current":-6.912426,"twenty":-7.480081,"median":-7.023469,"eighty":-6.753459,"marketCap":5828099229},{"date":"2023-07-14","current":-6.415246,"twenty":-7.354402,"median":-6.80281,"eighty":-6.620389,"marketCap":5484810921},{"date":"2023-07-21","current":-6.50021,"twenty":-7.00126,"median":-6.637911,"eighty":-6.415921,"marketCap":5531622963},{"date":"2023-07-28","current":-6.387862,"twenty":-6.910347,"median":-6.626959,"eighty":-6.393338,"marketCap":5430196872},{"date":"2023-08-04","current":-6.872048,"twenty":-6.916775,"median":-6.645885,"eighty":-6.415921,"marketCap":5851505250},{"date":"2023-08-11","current":-8.062915,"twenty":-7.354402,"median":-6.732662,"eighty":-6.423028,"marketCap":6826756125},{"date":"2023-08-18","current":-6.496848,"twenty":-7.428921,"median":-6.729682,"eighty":-6.45189,"marketCap":5461404900},{"date":"2023-08-25","current":-8.440637,"twenty":-7.525288,"median":-6.804775,"eighty":-6.49752,"marketCap":6327427677},{"date":"2023-09-01","current":-9.089804,"twenty":-8.007442,"median":-6.902032,"eighty":-6.501491,"marketCap":6842360139},{"date":"2023-09-08","current":-6.586545,"twenty":-8.136633,"median":-6.907229,"eighty":-6.507456,"marketCap":4899660396},{"date":"2023-09-15","current":-5.932237,"twenty":-8.007442,"median":-6.869978,"eighty":-6.423028,"marketCap":4447143990},{"date":"2023-09-22","current":-6.606383,"twenty":-7.784235,"median":-6.883282,"eighty":-6.45189,"marketCap":4930868424},{"date":"2023-09-29","current":-7.14814,"twenty":-7.744431,"median":-6.894516,"eighty":-6.45189,"marketCap":5344374795},{"date":"2023-10-06","current":-7.631816,"twenty":-7.631816,"median":-6.912426,"eighty":-6.496848,"marketCap":5703267117},{"date":"2023-10-13","current":-8.856112,"twenty":-8.155063,"median":-6.923868,"eighty":-6.50021,"marketCap":6608299929},{"date":"2023-10-20","current":-8.199572,"twenty":-8.313082,"median":-7.000277,"eighty":-6.506614,"marketCap":6108971481},{"date":"2023-10-27","current":-9.816471,"twenty":-8.453817,"median":-7.029823,"eighty":-6.509983,"marketCap":7310480559},{"date":"2023-11-03","current":-11.65035,"twenty":-8.539495,"median":-7.190868,"eighty":-6.562195,"marketCap":8699237805},{"date":"2023-11-10","current":-10.973476,"twenty":-8.805599,"median":-7.285091,"eighty":-6.584244,"marketCap":8192107350},{"date":"2023-11-17","current":-11.729885,"twenty":-9.08956,"median":-7.4166,"eighty":-6.600627,"marketCap":8835772927},{"date":"2023-11-24","current":-11.685472,"twenty":-9.394133,"median":-7.490817,"eighty":-6.605936,"marketCap":8874782962},{"date":"2023-12-01","current":-9.84176,"twenty":-10.15546,"median":-7.577915,"eighty":-6.610422,"marketCap":7505530734},{"date":"2023-12-08","current":-7.796477,"twenty":-9.900606,"median":-7.778973,"eighty":-6.615093,"marketCap":5921723313},{"date":"2023-12-15","current":-9.518573,"twenty":-9.821529,"median":-7.782262,"eighty":-6.63353,"marketCap":7271470524},{"date":"2023-12-22","current":-9.095699,"twenty":-9.838318,"median":-7.864399,"eighty":-6.64429,"marketCap":6943786230},{"date":"2023-12-29","current":-10.114857,"twenty":-10.007865,"median":-8.108989,"eighty":-6.673018,"marketCap":7762996965},{"date":"2024-01-05","current":-7.064143,"twenty":-9.846254,"median":-7.963657,"eighty":-6.71691,"marketCap":5383384830},{"date":"2024-01-12","current":-6.507833,"twenty":-9.8409,"median":-7.785551,"eighty":-6.71691,"marketCap":4962076452},{"date":"2024-01-19","current":-6.147909,"twenty":-9.833261,"median":-7.674627,"eighty":-6.639506,"marketCap":4681204200},{"date":"2024-01-26","current":-4.037471,"twenty":-9.789285,"median":-7.606263,"eighty":-6.604594,"marketCap":3062287747},{"date":"2024-02-02","current":-1.910591,"twenty":-9.668744,"median":-7.523229,"eighty":-6.508431,"marketCap":1447272298},{"date":"2024-02-09","current":-1.972972,"twenty":-9.600955,"median":-7.449769,"eighty":-6.45189,"marketCap":1501886347},{"date":"2024-02-16","current":-2.11088,"twenty":-9.539168,"median":-7.4166,"eighty":-6.417948,"marketCap":1607213442},{"date":"2024-02-23","current":-1.782124,"twenty":-9.334553,"median":-7.285091,"eighty":-6.285716,"marketCap":1349747211},{"date":"2024-03-01","current":-3.73704,"twenty":-9.184661,"median":-7.220535,"eighty":-6.16588,"marketCap":2832128541},{"date":"2024-03-08","current":-3.812556,"twenty":-9.158571,"median":-7.14814,"eighty":-5.783471,"marketCap":2890643593},{"date":"2024-03-15","current":-3.774736,"twenty":-9.108268,"median":-7.054895,"eighty":-5.122231,"marketCap":2859435565},{"date":"2024-03-22","current":-3.314294,"twenty":-9.090983,"median":-7.029823,"eighty":-4.16949,"marketCap":2508345250},{"date":"2024-03-28","current":-5.557677,"twenty":-9.089621,"median":-7.000277,"eighty":-4.108477,"marketCap":2219670991},{"date":"2024-04-05","current":-4.994454,"twenty":-9.061533,"median":-6.958518,"eighty":-4.159233,"marketCap":1993412788},{"date":"2024-04-12","current":-4.698569,"twenty":-8.939101,"median":-6.914215,"eighty":-4.187247,"marketCap":1876382683},{"date":"2024-04-19","current":-5.074098,"twenty":-8.895252,"median":-6.907229,"eighty":-4.270544,"marketCap":2024620816},{"date":"2024-04-26","current":-6.049449,"twenty":-8.886537,"median":-6.872048,"eighty":-4.439166,"marketCap":2410820163},{"date":"2024-05-03","current":-6.122202,"twenty":-8.8768,"median":-6.815159,"eighty":-4.698569,"marketCap":2438127187},{"date":"2024-05-10","current":-6.43996,"twenty":-8.86224,"median":-6.755587,"eighty":-4.994454,"marketCap":2570761306},{"date":"2024-05-17","current":-7.203002,"twenty":-8.857338,"median":-6.782134,"eighty":-5.0499,"marketCap":2871138576},{"date":"2024-05-24","current":-4.794357,"twenty":-8.851703,"median":-6.739573,"eighty":-4.885401,"marketCap":2754108471},{"date":"2024-05-31","current":-4.572395,"twenty":-8.804497,"median":-6.721699,"eighty":-4.757241,"marketCap":2629276359},{"date":"2024-06-07","current":-4.421848,"twenty":-8.685949,"median":-6.645885,"eighty":-4.615745,"marketCap":2539553278},{"date":"2024-06-14","current":-3.882014,"twenty":-8.64394,"median":-6.616008,"eighty":-4.537135,"marketCap":2227472998},{"date":"2024-06-21","current":-3.862906,"twenty":-8.598267,"median":-6.605265,"eighty":-4.402835,"marketCap":2211868984},{"date":"2024-06-28","current":-3.550986,"twenty":-8.56584,"median":-6.575038,"eighty":-4.108477,"marketCap":2032422823},{"date":"2024-07-05","current":-3.292704,"twenty":-8.553381,"median":-6.507833,"eighty":-3.906941,"marketCap":1884184690},{"date":"2024-07-12","current":-3.669077,"twenty":-8.541472,"median":-6.498529,"eighty":-3.863311,"marketCap":2102640886},{"date":"2024-07-19","current":-2.927038,"twenty":-8.530589,"median":-6.44065,"eighty":-3.81922,"marketCap":1677431505},{"date":"2024-07-26","current":-2.773786,"twenty":-8.516747,"median":-6.41868,"eighty":-3.760814,"marketCap":1595510431},{"date":"2024-08-02","current":-3.12148,"twenty":-8.510893,"median":-6.387862,"eighty":-3.652511,"marketCap":1794461610},{"date":"2024-08-09","current":-2.9997,"twenty":-8.480176,"median":-6.325017,"eighty":-3.53511,"marketCap":1735946557},{"date":"2024-08-16","current":-3.214159,"twenty":-8.413826,"median":-6.28512,"eighty":-3.427,"marketCap":1860778669},{"date":"2024-08-23","current":-6.604067,"twenty":-8.372166,"median":-6.272718,"eighty":-3.478589,"marketCap":2129947911},{"date":"2024-08-30","current":-6.163541,"twenty":-8.347233,"median":-6.28512,"eighty":-3.497821,"marketCap":2001214795},{"date":"2024-09-06","current":-5.314921,"twenty":-8.300967,"median":-6.252611,"eighty":-3.516857,"marketCap":1726510663},{"date":"2024-09-13","current":-5.032211,"twenty":-8.277822,"median":-6.194778,"eighty":-3.53511,"marketCap":1630395636},{"date":"2024-09-20","current":-5.111432,"twenty":-8.256206,"median":-6.170373,"eighty":-3.56099,"marketCap":1665993794},{"date":"2024-09-27","current":-6.057967,"twenty":-8.195708,"median":-6.135055,"eighty":-3.605108,"marketCap":1986377216},{"date":"2024-10-04","current":-7.03444,"twenty":-8.180254,"median":-6.166957,"eighty":-3.621517,"marketCap":2296081191},{"date":"2024-10-10","current":-6.311883,"twenty":-8.160101,"median":-6.193894,"eighty":-3.641637,"marketCap":2046894085},{"date":"2024-10-18","current":-9.026405,"twenty":-8.160101,"median":-6.241014,"eighty":-3.658355,"marketCap":2911929324},{"date":"2024-10-25","current":-10.329157,"twenty":-8.288852,"median":-6.25781,"eighty":-3.667517,"marketCap":3331987588},{"date":"2024-11-01","current":-10.068556,"twenty":-8.453817,"median":-6.28512,"eighty":-3.723447,"marketCap":3250111825},{"date":"2024-11-08","current":-11.890039,"twenty":-8.539495,"median":-6.303819,"eighty":-3.748634,"marketCap":3809002906},{"date":"2024-11-15","current":-12.473246,"twenty":-8.638855,"median":-6.337113,"eighty":-3.770095,"marketCap":3965634801},{"date":"2024-11-22","current":-15.548537,"twenty":-8.857338,"median":-6.401271,"eighty":-3.792036,"marketCap":4941024330},{"date":"2024-11-29","current":-16.918042,"twenty":-8.907392,"median":-6.418623,"eighty":-3.798946,"marketCap":5372620800},{"date":"2024-12-06","current":-17.028741,"twenty":-9.08956,"median":-6.440305,"eighty":-3.809963,"marketCap":5395037855},{"date":"2024-12-13","current":-14.037501,"twenty":-9.184661,"median":-6.496848,"eighty":-3.825885,"marketCap":4438576850},{"date":"2024-12-20","current":-10.693671,"twenty":-9.519989,"median":-6.507224,"eighty":-3.843767,"marketCap":3366294395},{"date":"2024-12-27","current":-10.761363,"twenty":-9.613258,"median":-6.510825,"eighty":-3.853605,"marketCap":3384975274},{"date":"2025-01-03","current":-12.815569,"twenty":-9.789285,"median":-6.563121,"eighty":-3.862906,"marketCap":4035069864},{"date":"2025-01-10","current":-14.889249,"twenty":-9.925093,"median":-6.595306,"eighty":-3.863109,"marketCap":4670219750},{"date":"2025-01-17","current":-11.842286,"twenty":-10.213871,"median":-6.606383,"eighty":-3.864484,"marketCap":3717494921},{"date":"2025-01-24","current":-10.786847,"twenty":-10.358151,"median":-6.624251,"eighty":-3.867614,"marketCap":3407392329},{"date":"2025-01-28","current":-10.88357,"twenty":-10.395234,"median":-6.635203,"eighty":-3.869357,"marketCap":3455962615},{"date":"2025-02-07","current":-10.247352,"twenty":-10.395234,"median":-6.668158,"eighty":-3.877648,"marketCap":3235528242},{"date":"2025-02-14","current":-10.714001,"twenty":-10.679993,"median":-6.721699,"eighty":-3.919404,"marketCap":3381239099},{"date":"2025-02-21","current":-14.934496,"twenty":-10.737429,"median":-6.739573,"eighty":-3.995096,"marketCap":4729998562},{"date":"2025-02-28","current":-14.81818,"twenty":-10.833722,"median":-6.801774,"eighty":-4.034059,"marketCap":4677692101},{"date":"2025-03-07","current":-17.375919,"twenty":-11.045086,"median":-6.869978,"eighty":-4.108477,"marketCap":5507123129},{"date":"2025-03-14","current":-16.002657,"twenty":-11.141514,"median":-6.898274,"eighty":-4.166071,"marketCap":5073726736},{"date":"2025-03-21","current":-15.584553,"twenty":-11.292034,"median":-6.914215,"eighty":-4.215924,"marketCap":4939224407},{"date":"2025-03-28","current":-19.960729,"twenty":-11.418322,"median":-6.958518,"eighty":-4.322429,"marketCap":5432399613},{"date":"2025-04-03","current":-17.71685,"twenty":-11.522026,"median":-7.011873,"eighty":-4.393328,"marketCap":4812194430},{"date":"2025-04-11","current":-14.733536,"twenty":-11.702518,"median":-7.03444,"eighty":-4.445369,"marketCap":3975291051},{"date":"2025-04-17","current":-15.831036,"twenty":-11.83884,"median":-7.042573,"eighty":-4.481028,"marketCap":4281657466}],"updateTime":1745135049329}}}